During this presentation, you will:
- Gain exposure to NGS panel trends observed by Ambry Genetics
- Examine pathogenic results observed in patients not meeting diagnostic criteria for single gene testing or a hereditary cancer syndrome
- Compare the strengths, limitations, and differences between multi-gene panels and whole exome sequencing
- Assess the utility of whole exome sequencing in suspected hereditary cancer syndromes
- Review novel gene analysis interpretation and positive results attributed to previously uncharacterized genes.
